Resources
Whether you’re looking for a specific case study or just exploring, you’ll find all the resources you need on this page.
Waystar named one of Forbes’ Most Trusted Companies in America
Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, announced today that Forbes recognized Waystar as one of the Most Trusted Companies in America, alongside many of the world's leading software companies.
Waystar to Announce Third Quarter 2024 Financial Results on November 6, 2024
Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the third quarter ended September 30, 2024, after market close on Wednesday, November 6, 2024.
New Research from Waystar and Modern Healthcare Reveals AI’s Transformative Impact on Healthcare Payments
Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, and Modern Healthcare, today announced new research that reveals how artificial intelligence (AI) transforms healthcare payments.
Waystar Wins Stevie® Awards for Company of the Year and AI Solutions in Healthcare
Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that it has been recognized with a series of Stevie® Awards as part of the 2024 International Business Awards® (IBAs).
Waystar CEO to Speak at Canaccord Genuity Growth Conference
LEHI, Utah and LOUISVILLE, Ky., August 9, 2024 — Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins will speak at the Canaccord Genuity Growth Conference on Tuesday, August 13, 2024, at 10:00 a.m. EST.
Waystar announces term loan repricing and credit rating upgrades from Fitch, Moody’s, and S&P Global
Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that it has entered into an amendment to its first lien credit agreement (the “amended credit agreement”) with its lenders to reprice term loans. Under the terms of the amended credit agreement, the term loan borrowings will now carry a reduced interest rate of adjusted SOFR +2.75%, compared to the previous interest rate of adjusted SOFR +4.00%. The amended credit agreement is expected to reduce Waystar’s cost of borrowing and allow for interest expense savings.
Waystar wins “Healthcare Payments Innovation Award,” marking its third consecutive MedTech Breakthrough Award
Waystar Technologies, Inc., a provider of leading healthcare payment technology, today announced that it has been selected as the winner of the “Healthcare Payments Innovation Award” in the annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough.
New industry research reveals financial impact of adopting a platform software strategy in healthcare payments
Waystar Technologies, Inc., a provider of leading healthcare payment technology, and The Health Management Academy (THMA) today announced the results of a study designed to examine the financial and operational impacts of revenue cycle management (“RCM”) software consolidation at leading health systems with greater than $2 billion in total operating revenue.
Waystar Announces Public Filing of Registration Statement for Proposed Initial Public Offering
Waystar Technologies, Inc., a provider of leading healthcare payment technology, today announced that its parent company, Waystar Holding Corp., has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of the parent company's common stock.
Waystar Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
Waystar Technologies, Inc., a provider of leading healthcare payment technology, today announced that its parent company, Waystar Holding Corp., has confidentially submitted a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of the parent company's common stock.